Socioeconomic Status Drives Racial Disparities in HPV‐negative Head and Neck Cancer Outcomes
Male
Squamous Cell Carcinoma of Head and Neck
Health Status Disparities
Middle Aged
White People
3. Good health
Black or African American
Survival Rate
03 medical and health sciences
Logistic Models
0302 clinical medicine
Social Class
Head and Neck Neoplasms
North Carolina
Humans
Female
Aged
Neoplasm Staging
Proportional Hazards Models
Retrospective Studies
DOI:
10.1002/lary.29252
Publication Date:
2020-11-10T22:36:27Z
AUTHORS (12)
ABSTRACT
Objectives/HypothesisTo determine drivers of the racial disparity in stage at diagnosis and overall survival (OS) between black and white patients with HPV‐negative head and neck squamous cell carcinoma (HNSCC).Study DesignRetrospective cohort study.MethodsData were examined from of a population‐based HNSCC study in North Carolina. Multivariable logistic regression and Cox proportional hazards models were used to assess racial disparities in stage at diagnosis and OS with sequential adjustment sets.ResultsA total of 340 black patients and 864 white patients diagnosed with HPV‐negative HNSCC were included. In the unadjusted model, black patients had increased odds of advanced T stage at diagnosis (OR 2.0; 95% CI [1.5–2.5]) and worse OS (HR 1.3, 95% CI 1.1–1.6) compared to white patients. After adjusting for age, sex, tumor site, tobacco use, and alcohol use, the racial disparity persisted for advanced T‐stage at diagnosis (OR 1.7; 95% CI [1.3–2.3]) and showed a non‐significant trend for worse OS (HR 1.1, 95% CI 0.9–1.3). After adding SES to the adjustment set, the association between race and stage at diagnosis was lost (OR: 1.0; 95% CI [0.8–1.5]). Further, black patients had slightly favorable OS compared to white patients (HR 0.8, 95% CI [0.6–1.0]; P = .024).ConclusionsSES has an important contribution to the racial disparity in stage at diagnosis and OS for HPV‐negative HNSCC. Low SES can serve as a target for interventions aimed at mitigating the racial disparities in head and neck cancer.Level of Evidence4 Laryngoscope, 131:1301–1309, 2021
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (48)
CITATIONS (18)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....